Cullinan Therapeutics, Inc. (CGEM)
(Delayed Data from NSDQ)
$19.91 USD
-0.40 (-1.97%)
Updated Jul 25, 2024 04:00 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.73 |
EPS Last Quarter | -0.86 |
Last EPS Surprise | 4.44% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.02 |
Next Year | -3.07 |
EPS (TTM) | -3.13 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 15.00M | 50.68M |
# of Estimates | NA | NA | 1 | 2 |
High Estimate | NA | NA | 15.00M | 53.64M |
Low Estimate | NA | NA | 15.00M | 47.71M |
Year ago Sales | 0.00M | 0.00M | NA | 15.00M |
Year over Year Growth Est. | NA | NA | NA | 237.83% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.73 | -0.74 | -3.02 | -3.07 |
# of Estimates | 7 | 6 | 7 | 7 |
Most Recent Consensus | -0.74 | -0.73 | -3.11 | -2.75 |
High Estimate | -0.62 | -0.68 | -2.69 | -2.23 |
Low Estimate | -0.89 | -0.84 | -3.35 | -4.21 |
Year ago EPS | -0.82 | -0.91 | -3.69 | -3.02 |
Year over Year Growth Est. | 10.98% | 18.68% | 18.16% | -1.71% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.73 | -0.74 | -3.02 | -3.07 |
7 Days Ago | -0.73 | -0.74 | -3.02 | -3.07 |
30 Days Ago | -0.73 | -0.74 | -3.02 | -3.07 |
60 Days Ago | -0.73 | -0.74 | -3.02 | -3.07 |
90 Days Ago | -0.77 | -0.75 | -3.21 | -3.03 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.73 | -0.74 | -3.02 | -3.07 |
Zacks Consensus Estimate | -0.73 | -0.74 | -3.02 | -3.07 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.86 | -0.54 | -0.91 | -0.82 | NA |
Estimate | -0.90 | -0.96 | -0.91 | -0.99 | NA |
Difference | 0.04 | 0.42 | 0.00 | 0.17 | 0.16 |
Surprise | 4.44% | 43.75% | 0.00% | 17.17% | 16.34% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more